November 20, 2014 BY LeapRate Staff
SEC suspends trading in shares of questionable Ebola prevention and treatment companies
The US Securities and Exchange Commission (SEC) today suspended trading in four companies that claim to be developing products or services in response to the Ebola outbreak, citing a lack of publicly available information about the companies’ operations. The SEC simultaneously issued an investor alert warning about the potential for fraud in microcap companies purportedly…
Read more